These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 17552921

  • 1. Proteomic analysis of bone cancer: a review of current and future developments.
    Bhattacharyya S, Byrum S, Siegel ER, Suva LJ.
    Expert Rev Proteomics; 2007 Jun; 4(3):371-8. PubMed ID: 17552921
    [Abstract] [Full Text] [Related]

  • 2. The promise of bone cancer proteomics.
    Byrum S, Montgomery CO, Nicholas RW, Suva LJ.
    Ann N Y Acad Sci; 2010 Mar; 1192():222-9. PubMed ID: 20392240
    [Abstract] [Full Text] [Related]

  • 3. Proteomics analysis in lung cancer: challenges and opportunities.
    Kikuchi T, Carbone DP.
    Respirology; 2007 Jan; 12(1):22-8. PubMed ID: 17207021
    [Abstract] [Full Text] [Related]

  • 4. Practical approaches to proteomic biomarkers within prostate cancer radiotherapy trials.
    Christensen E, Evans KR, Ménard C, Pintilie M, Bristow RG.
    Cancer Metastasis Rev; 2008 Sep; 27(3):375-85. PubMed ID: 18427732
    [Abstract] [Full Text] [Related]

  • 5. Clinical proteomics in breast cancer: a review.
    Gast MC, Schellens JH, Beijnen JH.
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Molecular markers of prostate cancer.
    Bradford TJ, Tomlins SA, Wang X, Chinnaiyan AM.
    Urol Oncol; 2006 Jul; 24(6):538-51. PubMed ID: 17138135
    [Abstract] [Full Text] [Related]

  • 8. Oncoproteomics: current trends and future perspectives.
    Cho WC, Cheng CH.
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [Abstract] [Full Text] [Related]

  • 9. Proteomics of breast cancer: the quest for markers and therapeutic targets.
    Hondermarck H, Tastet C, El Yazidi-Belkoura I, Toillon RA, Le Bourhis X.
    J Proteome Res; 2008 Apr; 7(4):1403-11. PubMed ID: 18311906
    [Abstract] [Full Text] [Related]

  • 10. The evolving role of proteomics in the early detection of breast cancer.
    Pawlik TM, Kuerer HM.
    Int J Fertil Womens Med; 2005 Apr; 50(5 Pt 1):212-6. PubMed ID: 16468471
    [Abstract] [Full Text] [Related]

  • 11. Proteomics: addressing the challenges of multiple myeloma.
    Ge F, Tao S, Bi L, Zhang Z, Zhang X.
    Acta Biochim Biophys Sin (Shanghai); 2011 Feb; 43(2):89-95. PubMed ID: 21212069
    [Abstract] [Full Text] [Related]

  • 12. The potentials of MS-based subproteomic approaches in medical science: the case of lysosomes and breast cancer.
    Journet A, Ferro M.
    Mass Spectrom Rev; 2004 Feb; 23(6):393-442. PubMed ID: 15290709
    [Abstract] [Full Text] [Related]

  • 13. NMR-based metabolomics approach to target biomarkers for human prostate cancer.
    Jordan KW, Cheng LL.
    Expert Rev Proteomics; 2007 Jun; 4(3):389-400. PubMed ID: 17552923
    [Abstract] [Full Text] [Related]

  • 14. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C, Liotta LA, Petricoin EF.
    Crit Rev Clin Lab Sci; 2010 Jun; 47(3):125-38. PubMed ID: 20858067
    [Abstract] [Full Text] [Related]

  • 15. Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.
    Sinchaikul S, Hongsachart P, Sriyam S, Tantipaiboonwong P, Phutrakul S, Chen ST.
    Chang Gung Med J; 2008 Jun; 31(5):417-30. PubMed ID: 19097588
    [Abstract] [Full Text] [Related]

  • 16. Cancer biomarkers: knowing the present and predicting the future.
    Chatterjee SK, Zetter BR.
    Future Oncol; 2005 Feb; 1(1):37-50. PubMed ID: 16555974
    [Abstract] [Full Text] [Related]

  • 17. Computational methods for comparison of large genomic and proteomic datasets reveal protein markers of metastatic cancer.
    Wang Y, Hanley R, Klemke RL.
    J Proteome Res; 2006 Apr; 5(4):907-15. PubMed ID: 16602698
    [Abstract] [Full Text] [Related]

  • 18. Clinical applications of expression profiling and proteomics in prostate cancer.
    Masters JR.
    Anticancer Res; 2007 Apr; 27(3A):1273-6. PubMed ID: 17593619
    [Abstract] [Full Text] [Related]

  • 19. High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy.
    Davis MA, Hanash S.
    Breast Cancer Res; 2006 Apr; 8(6):217. PubMed ID: 17184556
    [Abstract] [Full Text] [Related]

  • 20. Urological malignancies and the proteomic-genomic interface.
    Unwin RD, Knowles MA, Selby PJ, Banks RE.
    Electrophoresis; 1999 Dec; 20(18):3629-37. PubMed ID: 10612290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.